There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Aerie Pharma (AERI – Research Report) with bullish sentiments.
Aerie Pharma (AERI)
Needham analyst Serge Belanger assigned a Buy rating to Aerie Pharma on December 27 and set a price target of $22.00. The company’s shares closed last Friday at $7.02.
According to TipRanks.com, Belanger is a 3-star analyst with an average return of
Aerie Pharma has an analyst consensus of Strong Buy, with a price target consensus of $24.00.
See the top stocks recommended by analysts >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AERI:
